Key facts
- This page summarizes Woodrow D. Anderson's Form 4 filing for Indivior Pharmaceuticals, Inc. (INDV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2026, 16:52.
Woodrow D. Anderson - 05 Aug 2026 Form 4 Insider Report for Indivior Pharmaceuticals, Inc. (INDV)
- Reporting relationship
- Chief Accounting Officer
- Issuer ticker
- INDV
- Reported as of
- 05 Aug 2026
- Net transaction value
- +$54,420
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2026, 16:52:07 UTC
- Prior SEC filing
- 05 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/Alice Givens, Power of Attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Woodrow D. Anderson filed Form 4 for Indivior Pharmaceuticals, Inc. (INDV) on 05 Aug 2026.
Change
- Previous filing in this sequence was filed on 05 Mar 2026.
- Current net transaction value: +$54,420.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002014440
Primary reporting owner
Anderson Woodrow D
- Relationship
- Chief Accounting Officer
- Address
- 10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD
- Signature
- /s/Alice Givens, Power of Attorney
- Signature date
- 05 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INDV
transaction
Common Stock
Purchase
- Transaction value
- $54,420
- Shares
- +1,500
- Change %
- +6.1%
- Price
- $36.28
- Shares after
- 26,138
- Date
- 05 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.